No Data
No Data
DocGo Announces Participation at Three Upcoming Investor Conferences
Do Its Financials Have Any Role To Play In Driving DocGo Inc.'s (NASDAQ:DCGO) Stock Up Recently?
Northland Securities Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $8
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and DocGo (DCGO)
Stifel Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $6.5
Deutsche Bank Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $5